CPT1A and head and neck squamous cell carcinoma: Moreover, we observed reduced sensitivity to the tricarboxylic acid (TCA) cycle inhibitor CPI‐613 in FAT1‐mutant HNSCC cells, a phenomenon mechanistically associated with increased FAO driven by CPT1A.